| Market Cap | 88.19M | P/E | - | EPS this Y | - | Ern Qtrly Grth | - |
| Income | -4.81M | Forward P/E | - | EPS next Y | - | 50D Avg Chg | 8.00% |
| Sales | 2.09M | PEG | - | EPS past 5Y | - | 200D Avg Chg | 6.00% |
| Dividend | N/A | Price/Book | 3.56 | EPS next 5Y | - | 52W High Chg | -46.00% |
| Recommedations | - | Quick Ratio | 7.25 | Shares Outstanding | 167.30M | 52W Low Chg | 122.00% |
| Insider Own | 2.85% | ROA | -15.68% | Shares Float | 136.62M | Beta | 1.94 |
| Inst Own | 50.97% | ROE | -21.33% | Shares Shorted/Prior | -/- | Price | 0.56 |
| Gross Margin | 48.25% | Profit Margin | -230.24% | Avg. Volume | 56,724 | Target Price | - |
| Oper. Margin | -417.64% | Earnings Date | Jul 11 | Volume | 15,892 | Change | -2.12% |
Ilika plc engages in the design, production, and development of solid state batteries in the United Kingdom, Asia, Europe, and North America. The company offers solid state batteries for transportation under the Goliath name for electric vehicles and cordless consumer electronics. It also provides solid state batteries for healthcare under the Stereax name for neurostimulation, cardiac sensing, smart orthopaedics, smart orthodontics, smart contact lenses, and industrial IoT sensors. Ilika plc was founded in 2004 and is headquartered in Romsey, the United Kingdom.
